Benefit and Safety of Fluticasone Furoate/Vilanterol in the Salford Lung Study in Chronic Obstructive Pulmonary Disease (SLS COPD) According to Baseline Patient Characteristics and Treatment Subgroups
Respiratory Medicine - United Kingdom
doi 10.1016/j.rmed.2018.12.016
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Elsevier BV